Literature DB >> 25904510

Persistence and spreading of field and vaccine strains of infectious laryngotracheitis virus (ILTV) in vaccinated and unvaccinated geographic regions, in Brazil.

Jorge Luis Chacón1, Luis Fabian Naranjo Núñez, Maria Pilar Vejarano, Silvana Hipatia Santander Parra, Claudete Serrano Astolfi-Ferreira, Antonio José Piantino Ferreira.   

Abstract

Infectious laryngotracheitis (ILT) is a highly infectious respiratory disease that causes morbidity and mortality in commercial chickens. Despite the use of attenuated vaccines, ILT outbreaks have been described in broiler and long-lived birds. Molecular approaches, including polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing, are used to characterize ILT viruses (ILTVs) detected in vaccinated and unvaccinated geographical regions. As part of an ILT control program implemented in a region of commercial layer production, samples of conjunctiva, trachea, and trigeminal ganglia were collected from chickens in a vaccinated and quarantined region over a period of 8 years after initiation of vaccination. To determine the origin of new ILT outbreaks in unvaccinated regions, samples collected from ill chickens were also analyzed. Chicken embryo origin (CEO) vaccine viruses and the Bastos field strain were detected circulating in healthy chickens in the vaccinated region. CEO strains and field viruses molecularly related to the Bastos strain were also detected outside of the quarantined region in chickens showing clinical signs of ILT. This study reveals the persistence and circulation of a wild field strain, despite the intensive use of tissue culture origin (TCO) and CEO vaccines in a quarantined region. Spreading of CEO viruses to unvaccinated regions and the capacity of this virus to establish latent infections and cause severe outbreaks were also observed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25904510     DOI: 10.1007/s11250-015-0834-3

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  26 in total

1.  Latency and reactivation of infectious laryngotracheitis vaccine virus.

Authors:  C S Hughes; R A Williams; R M Gaskell; F T Jordan; J M Bradbury; M Bennett; R C Jones
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage.

Authors:  J S Guy; H J Barnes; L Smith
Journal:  Avian Dis       Date:  1991 Apr-Jun       Impact factor: 1.577

Review 3.  Epizootiology of infectious laryngotracheitis and presentation of an industry control program.

Authors:  Louise Dufour-Zavala
Journal:  Avian Dis       Date:  2008-03       Impact factor: 1.577

4.  Epidemic of infectious laryngotracheitis in Italy: characterization of virus isolates by PCR-restriction fragment length polymorphism and sequence analysis.

Authors:  Ana Moreno; Alessandra Piccirillo; Alessandra Mondin; Emilio Morandini; Luigi Gavazzi; Paolo Cordioli
Journal:  Avian Dis       Date:  2010-12       Impact factor: 1.577

5.  Differentiation of infectious laryngotracheitis virus isolates by restriction fragment length polymorphic analysis of polymerase chain reaction products amplified from multiple genes.

Authors:  Naomi C Kirkpatrick; Alireza Mahmoudian; Denise O'Rourke; Amir H Noormohammadi
Journal:  Avian Dis       Date:  2006-03       Impact factor: 1.577

6.  The development of a vaccine against avian infectious laryngotracheitis. IV. Immunization of chickens with a modified laryngotracheitis vaccine in the drinking water.

Authors:  Y Samberg; E Cuperstein; U Bendheim; I Aronovici
Journal:  Avian Dis       Date:  1971 Apr-Jun       Impact factor: 1.577

7.  Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken. 4. Latency establishment by wild and vaccine strains of ILT virus.

Authors:  T J Bagust
Journal:  Avian Pathol       Date:  1986       Impact factor: 3.378

8.  The effect of serial in vivo passage on the expression of virulence and DNA stability of an infectious laryngotracheitis virus strain of low virulence.

Authors:  M Kotiw; C R Wilks; J T May
Journal:  Vet Microbiol       Date:  1995-06       Impact factor: 3.293

9.  Avian infectious laryngotracheitis: virus-host interactions in relation to prospects for eradication.

Authors:  T J Bagust; M A Johnson
Journal:  Avian Pathol       Date:  1995-09       Impact factor: 3.378

10.  Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines.

Authors:  Andrés Rodríguez-Avila; Ivomar Oldoni; Sylva Riblet; Maricarmen García
Journal:  Avian Dis       Date:  2007-12       Impact factor: 1.577

View more
  9 in total

1.  Detection and molecular characterization of infectious laryngotracheitis virus (ILTV) in chicken with respiratory signs in Brazil during 2015 and 2016.

Authors:  Silvana H Santander-Parra; Luis F N Nuñez; Marcos R Buim; Claudete S Astolfi Ferreira; Carlos A Loncoman; Antonio J Piantino Ferreira
Journal:  Braz J Microbiol       Date:  2022-10-21       Impact factor: 2.214

2.  Host Responses Following Infection with Canadian-Origin Wildtype and Vaccine Revertant Infectious Laryngotracheitis Virus.

Authors:  Esraa A Elshafiee; Ishara M Isham; Shahnas M Najimudeen; Ana Perez-Contreras; Catalina Barboza-Solis; Madhu Ravi; Mohamed Faizal Abdul-Careem
Journal:  Vaccines (Basel)       Date:  2022-05-16

3.  Full Genome Sequence-Based Comparative Study of Wild-Type and Vaccine Strains of Infectious Laryngotracheitis Virus from Italy.

Authors:  Alessandra Piccirillo; Enrico Lavezzo; Giulia Niero; Ana Moreno; Paola Massi; Elisa Franchin; Stefano Toppo; Cristiano Salata; Giorgio Palù
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

4.  Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.

Authors:  Dulari S Thilakarathne; Mauricio J C Coppo; Carol A Hartley; Andrés Diaz-Méndez; José A Quinteros; Omid Fakhri; Paola K Vaz; Joanne M Devlin
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

5.  Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control - a comprehensive review.

Authors:  Vasudevan Gowthaman; Sachin Kumar; Monika Koul; Urmil Dave; T R Gopala Krishna Murthy; Palanivelu Munuswamy; Ruchi Tiwari; Kumaragurubaran Karthik; Kuldeep Dhama; Izabela Michalak; Sunil K Joshi
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

6.  Multilocus analysis of Gallid herpesvirus 1 in layer chickens in Iraq.

Authors:  Mohammed Hamzah Abdulkadhim Al-Saadi
Journal:  Vet World       Date:  2020-01-24

7.  Analysis of Whole-Genome Sequences of Infectious laryngotracheitis Virus Isolates from Poultry Flocks in Canada: Evidence of Recombination.

Authors:  Ana Perez Contreras; Frank van der Meer; Sylvia Checkley; Tomy Joseph; Robin King; Madhu Ravi; Delores Peters; Kevin Fonseca; Carl A Gagnon; Chantale Provost; Davor Ojkic; Mohamed Faizal Abdul-Careem
Journal:  Viruses       Date:  2020-11-12       Impact factor: 5.048

8.  Genotyping of Infectious Laryngotracheitis Virus (ILTV) Isolates from Western Canadian Provinces of Alberta and British Columbia Based on Partial Open Reading Frame (ORF) a and b.

Authors:  Catalina Barboza-Solis; Ana Perez Contreras; Victor A Palomino-Tapia; Tommy Joseph; Robin King; Madhu Ravi; Delores Peters; Kevin Fonseca; Carl A Gagnon; Frank van der Meer; Mohamed Faizal Abdul-Careem
Journal:  Animals (Basel)       Date:  2020-09-11       Impact factor: 2.752

9.  Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.

Authors:  Ana Perez-Contreras; Catalina Barboza-Solis; Shahnas M Najimudeen; Sylvia Checkley; Frank van der Meer; Tomy Joseph; Robin King; Madhu Ravi; Delores Peters; Kevin Fonseca; Carl A Gagnon; Davor Ojkic; Mohamed Faizal Abdul-Careem
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.